How RNA-based vaccines will revolutionize medicine and disease treatments

Credit: Financial Times
Credit: Financial Times

The two vaccine candidates produced by Pfizer/BioNTech and Moderna are unlike any other vaccine that’s come before. Should they achieve commercial success, it could usher in a new era of medical science — not just for vaccines, but for cancer treatments, blood disorders, and gene therapy.

The two new vaccines are the first ever to use mRNA, which stands for “messenger RNA,” to generate immunity.

An up-and-coming strategy for fighting cancer is a so-called “cancer vaccine,” which uses immune cells called dendritic cells (DCs). DCs perform surveillance for the immune system. When they detect something that shouldn’t be there, whether it’s a virus, a bacteria, or even a cancer cell, the DCs chew it up, break it into its component molecules, and then show those foreign molecules to the immune cells that make antibodies.

Follow the latest news and policy debates on agricultural biotech and biomedicine? Subscribe to our newsletter.

Using mRNA to deliver the tumor antigen information to the DCs could provide a way to make this process easier, cheaper, and safer. BioNTech is currently conducting clinical trials on cancer vaccines for triple-negative breast cancer, metastatic melanoma, and HPV-positive head and neck cancers. Called FixVac, the vaccines include multiple tumor antigens that are frequently found across different patients.

Related article:  Viewpoint: DNA data 'rat race’ bringing down costs of precision medicine but perils of security risks escalate

Read the original post

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend